AGP Executive Report
Last update: 2 hours agoFDA & Pharma: NATCO Pharma won tentative FDA approval for generic olaparib tablets (100 mg/150 mg), but full U.S. availability hinges on unresolved patent/exclusivity fights tied to Paragraph IV litigation. Retirement Costs: New reporting highlights how 401(k) fees can quietly drain retirement outcomes—small percentage differences can translate into tens of thousands of dollars over decades. Healthcare Liability: Legal experts say the clinician who signs an AI-generated visit note is usually the one on the hook when errors slip into patient records. Payments & M&A: Deal talk is heating up in payments, with investors watching potential consolidation as firms look for AI and stablecoin capabilities. Housing Policy: The 21st Century ROAD to Housing Act became law July 11, aiming to expand supply and affordability through dozens of initiatives. Energy & Markets: A new report on big-and-bulky last-mile delivery shows demand softness but continued growth economics, while gold’s reaction to the U.S.-Iran conflict is complicated by higher oil and shipping costs. Crime & Enforcement: DOJ filed denaturalization suits against 10 people tied to alleged serious crimes, while a major cartel leader, “El Mayo” Zambada, received a life sentence in U.S. federal court.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
